This site is intended for Healthcare Professionals only.

BREAKING: Three more medicines banned from parallel export


Share post:

Lopinavir + Ritonavir, Chloroquine phosphate and Azathioprine have all been added to the list of medicines carrying a parallel export ban.

The restrictions will be in place from tomorrow, February 26.

The government first announced the ban on parallel export of 23 medicines in October to prevent shortages and later added nine more to the list including Ranitidine and MMR vaccines.

The list also includes Adrenaline auto-injectors, Hepatitis B vaccine, Hepatitis B (rDNA) suspension injection, Misoprostol, Pneumococcal Polysaccharide vaccine, and Hepatitis A and B vaccine.

In December, DHSC has lifted the ban on Alogliptin.

Any manufacturer or wholesaler found guilty of parallel exporting of one or more of the listed medicines could face immediate licence suspension.


Please enter your comment!
Please enter your name here

Current Issue March 2024

Related articles

Collaboration and partnership: The way forward with community pharmacy

Professor Mahendra G Patel elucidates how pharmacy professionals working in the multidisciplinary team can help to improve the...

Sigma Conference 2024: Sector says Pharmacy First won’t solve funding crisis

Demands for the next contractual framework include additional funding and write-off of any money that is owed, among...

Demand for private health cover surge amid NHS waiting list crisis

The UK health cover market was valued at £6.7 billion in 2022, marking a £385 million increase from...

Key Facts To Know Before Having a Blepharoplasty

It is very much a cultural thing. In Korea, having hooded eyes is seen as a sign of extreme...